Voyageur Advances Frances Creek Barite Project with VAST Engagement for Bulk Sample Permit

Core Viewpoint - Voyageur Pharmaceuticals Ltd. is advancing its Frances Creek Barite Mine project by engaging VAST Resource Solutions Inc. to prepare a Bulk Sample Permit Application, positioning itself as a key player in the North American pharmaceutical-grade barium sulfate supply chain [1][2]. Group 1: Project Development - The engagement with VAST is a significant step towards a full-scale feasibility study expected in 2026 [2]. - VAST will oversee a comprehensive scope of work, including environmental assessments and permit documentation, building on previous fieldwork completed in 2023 [3][6]. - The Frances Creek deposit is strategically important for reducing dependency on foreign materials and enhancing domestic production of pharmaceutical-grade barite [4][8]. Group 2: Business Strategy - Voyageur aims to vertically integrate the barium and iodine contrast markets, producing its own Active Pharmaceutical Ingredients (APIs) to enhance quality and cost-effectiveness [5][9]. - The company plans to partner with established third-party GMP pharmaceutical manufacturers in Canada to ensure product validation by regulatory agencies [6]. - Voyageur's vision includes becoming the first vertically integrated company in the radiology contrast media drug market, controlling all primary input costs from raw material sourcing to final production [9].